Form 4: Stryker Corp Executive William E. Berry, Jr. Reports Stock Option Exercises and Sales
SEC Form 4 Filing
William E. Berry, Jr., VP and Chief Accounting Officer of Stryker Corp, reports exercising stock options and selling shares on March 7th and 8th, 2024.
Summary
- On March 7th and 8th, 2024, William E. Berry, Jr., VP and Chief Accounting Officer of Stryker Corp, executed transactions involving Stryker's common stock.
- Berry exercised employee stock options to acquire 9,700 shares at $96.64 and 7,960 shares at $122.51 on March 7th.
- He also exercised options to acquire 1,480 shares at $154.14 on March 8th.
- On March 7th, Berry disposed of 9,970 shares at $355 and sold 7,690 shares at $358.4824.
- On March 8th, Berry disposed of 1,005 shares at $357.62.
- Following these transactions, Berry directly owns 4,150 shares of common stock and indirectly owns 561 shares through a 401K.
- He also holds options for 4,925 shares.
Sentiment
Score: 5
Explanation: Neutral sentiment as the document simply reports transactions. The exercising of options and selling of shares is a common practice.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's sentiment and actions regarding their company's stock.
Comparison to Industry Standards
- Monitoring insider transactions is a common practice in financial analysis.
- Comparing the ratio of stock options exercised versus shares sold can provide insights into an insider's confidence in the company's future performance.
- Similar filings from executives at comparable companies like Medtronic (MDT) or Johnson & Johnson (JNJ) could be analyzed to benchmark insider activity within the medical device industry.
Stakeholder Impact
- Shareholders may interpret these transactions as a signal, although routine, regarding management's view of the company's stock value.
- The transactions themselves have a minimal direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 02/10/2016 | Employee Stock Option granted (right to buy) at $96.64, exercisable as to 20% on each of the first five anniversaries of the date of grant. |
| 02/08/2017 | Employee Stock Option granted (right to buy) at $122.51, exercisable as to 20% on each of the first five anniversaries of the date of grant. |
| 02/07/2018 | Employee Stock Option granted (right to buy) at $154.14, exercisable as to 20% on each of the first five anniversaries of the date of grant. |
| 03/07/2024 | Earliest transaction date; stock options exercised and shares sold. |
| 03/08/2024 | Stock options exercised and shares disposed of. |
| 03/11/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.